nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—CYP3A4—bone cancer	0.469	1	CbGaD
Amprenavir—ABCC1—Epirubicin—bone cancer	0.133	0.285	CbGbCtD
Amprenavir—ABCC1—Doxorubicin—bone cancer	0.0706	0.151	CbGbCtD
Amprenavir—ABCC1—Methotrexate—bone cancer	0.0684	0.147	CbGbCtD
Amprenavir—CYP2B6—Cisplatin—bone cancer	0.0496	0.106	CbGbCtD
Amprenavir—CYP2B6—Doxorubicin—bone cancer	0.0332	0.0713	CbGbCtD
Amprenavir—CYP2C9—Cisplatin—bone cancer	0.0262	0.0562	CbGbCtD
Amprenavir—ABCB1—Cisplatin—bone cancer	0.0254	0.0545	CbGbCtD
Amprenavir—ABCB1—Doxorubicin—bone cancer	0.017	0.0366	CbGbCtD
Amprenavir—ABCB1—Methotrexate—bone cancer	0.0165	0.0354	CbGbCtD
Amprenavir—CYP2D6—Doxorubicin—bone cancer	0.0161	0.0344	CbGbCtD
Amprenavir—CYP3A4—Doxorubicin—bone cancer	0.0102	0.0219	CbGbCtD
Amprenavir—Fosamprenavir—CYP3A4—bone cancer	0.00376	0.5	CrCbGaD
Amprenavir—Darunavir—CYP3A4—bone cancer	0.00376	0.5	CrCbGaD
Amprenavir—CYP2B6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00107	0.0302	CbGpPWpGaD
Amprenavir—ABCC1—Irinotecan Pathway—CYP3A4—bone cancer	0.00106	0.03	CbGpPWpGaD
Amprenavir—Amylase increased—Cisplatin—bone cancer	0.00106	0.0485	CcSEcCtD
Amprenavir—CYP3A5—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00104	0.0295	CbGpPWpGaD
Amprenavir—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000902	0.0256	CbGpPWpGaD
Amprenavir—CYP2B6—Liver X Receptor Pathway—CYP3A4—bone cancer	0.000895	0.0254	CbGpPWpGaD
Amprenavir—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000862	0.0244	CbGpPWpGaD
Amprenavir—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNA11—bone cancer	0.000846	0.024	CbGpPWpGaD
Amprenavir—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000805	0.0228	CbGpPWpGaD
Amprenavir—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00079	0.0224	CbGpPWpGaD
Amprenavir—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000744	0.0211	CbGpPWpGaD
Amprenavir—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000741	0.021	CbGpPWpGaD
Amprenavir—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000739	0.0209	CbGpPWpGaD
Amprenavir—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000738	0.0209	CbGpPWpGaD
Amprenavir—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000734	0.0208	CbGpPWpGaD
Amprenavir—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000702	0.0199	CbGpPWpGaD
Amprenavir—Opportunistic infection—Methotrexate—bone cancer	0.000685	0.0315	CcSEcCtD
Amprenavir—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.000669	0.0189	CbGpPWpGaD
Amprenavir—Opportunistic infection—Epirubicin—bone cancer	0.000642	0.0295	CcSEcCtD
Amprenavir—Opportunistic infection—Doxorubicin—bone cancer	0.000594	0.0273	CcSEcCtD
Amprenavir—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000576	0.0163	CbGpPWpGaD
Amprenavir—Myositis—Epirubicin—bone cancer	0.000527	0.0242	CcSEcCtD
Amprenavir—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000524	0.0148	CbGpPWpGaD
Amprenavir—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000514	0.0146	CbGpPWpGaD
Amprenavir—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.000503	0.0142	CbGpPWpGaD
Amprenavir—Myositis—Doxorubicin—bone cancer	0.000487	0.0224	CcSEcCtD
Amprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000484	0.0137	CbGpPWpGaD
Amprenavir—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000483	0.0137	CbGpPWpGaD
Amprenavir—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000459	0.013	CbGpPWpGaD
Amprenavir—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000456	0.0129	CbGpPWpGaD
Amprenavir—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000448	0.0127	CbGpPWpGaD
Amprenavir—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000435	0.0123	CbGpPWpGaD
Amprenavir—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000432	0.0122	CbGpPWpGaD
Amprenavir—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000427	0.0121	CbGpPWpGaD
Amprenavir—Transaminases increased—Epirubicin—bone cancer	0.000425	0.0195	CcSEcCtD
Amprenavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000425	0.012	CbGpPWpGaD
Amprenavir—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000419	0.0119	CbGpPWpGaD
Amprenavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000397	0.0112	CbGpPWpGaD
Amprenavir—Transaminases increased—Doxorubicin—bone cancer	0.000393	0.018	CcSEcCtD
Amprenavir—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000389	0.011	CbGpPWpGaD
Amprenavir—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000388	0.011	CbGpPWpGaD
Amprenavir—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000374	0.0106	CbGpPWpGaD
Amprenavir—ABCC1—S1P1 pathway—PTGS2—bone cancer	0.000368	0.0104	CbGpPWpGaD
Amprenavir—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000357	0.0101	CbGpPWpGaD
Amprenavir—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000354	0.01	CbGpPWpGaD
Amprenavir—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000353	0.01	CbGpPWpGaD
Amprenavir—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000347	0.00982	CbGpPWpGaD
Amprenavir—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000345	0.00978	CbGpPWpGaD
Amprenavir—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000344	0.00974	CbGpPWpGaD
Amprenavir—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000341	0.00965	CbGpPWpGaD
Amprenavir—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000336	0.00953	CbGpPWpGaD
Amprenavir—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.000329	0.0151	CcSEcCtD
Amprenavir—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000319	0.00903	CbGpPWpGaD
Amprenavir—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000316	0.00895	CbGpPWpGaD
Amprenavir—Hyperbilirubinaemia—Methotrexate—bone cancer	0.000304	0.0139	CcSEcCtD
Amprenavir—Abdominal discomfort—Cisplatin—bone cancer	0.000303	0.0139	CcSEcCtD
Amprenavir—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.00029	0.00822	CbGpPWpGaD
Amprenavir—Inflammation—Methotrexate—bone cancer	0.000285	0.0131	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Epirubicin—bone cancer	0.000284	0.013	CcSEcCtD
Amprenavir—Acute coronary syndrome—Cisplatin—bone cancer	0.000277	0.0127	CcSEcCtD
Amprenavir—Myocardial infarction—Cisplatin—bone cancer	0.000276	0.0127	CcSEcCtD
Amprenavir—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000267	0.00756	CbGpPWpGaD
Amprenavir—Inflammation—Epirubicin—bone cancer	0.000266	0.0122	CcSEcCtD
Amprenavir—Hepatobiliary disease—Cisplatin—bone cancer	0.000266	0.0122	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Doxorubicin—bone cancer	0.000263	0.0121	CcSEcCtD
Amprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000262	0.00741	CbGpPWpGaD
Amprenavir—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00026	0.00738	CbGpPWpGaD
Amprenavir—Connective tissue disorder—Cisplatin—bone cancer	0.000248	0.0114	CcSEcCtD
Amprenavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000248	0.00703	CbGpPWpGaD
Amprenavir—Inflammation—Doxorubicin—bone cancer	0.000246	0.0113	CcSEcCtD
Amprenavir—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000243	0.00689	CbGpPWpGaD
Amprenavir—Cardiac disorder—Cisplatin—bone cancer	0.000234	0.0108	CcSEcCtD
Amprenavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000232	0.00657	CbGpPWpGaD
Amprenavir—Diabetes mellitus—Methotrexate—bone cancer	0.00023	0.0106	CcSEcCtD
Amprenavir—Malnutrition—Cisplatin—bone cancer	0.00022	0.0101	CcSEcCtD
Amprenavir—Flatulence—Cisplatin—bone cancer	0.000217	0.00995	CcSEcCtD
Amprenavir—Diabetes mellitus—Epirubicin—bone cancer	0.000216	0.0099	CcSEcCtD
Amprenavir—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000214	0.00605	CbGpPWpGaD
Amprenavir—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000211	0.00597	CbGpPWpGaD
Amprenavir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000209	0.00591	CbGpPWpGaD
Amprenavir—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000208	0.0059	CbGpPWpGaD
Amprenavir—Tremor—Cisplatin—bone cancer	0.000206	0.00946	CcSEcCtD
Amprenavir—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000206	0.00584	CbGpPWpGaD
Amprenavir—Diabetes mellitus—Doxorubicin—bone cancer	0.0002	0.00916	CcSEcCtD
Amprenavir—Myalgia—Cisplatin—bone cancer	0.000187	0.0086	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000186	0.00854	CcSEcCtD
Amprenavir—Liver function test abnormal—Methotrexate—bone cancer	0.000185	0.0085	CcSEcCtD
Amprenavir—Discomfort—Cisplatin—bone cancer	0.000185	0.00849	CcSEcCtD
Amprenavir—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000181	0.00512	CbGpPWpGaD
Amprenavir—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000178	0.00505	CbGpPWpGaD
Amprenavir—Nervous system disorder—Cisplatin—bone cancer	0.000176	0.00808	CcSEcCtD
Amprenavir—Skin disorder—Cisplatin—bone cancer	0.000174	0.00801	CcSEcCtD
Amprenavir—Liver function test abnormal—Epirubicin—bone cancer	0.000173	0.00795	CcSEcCtD
Amprenavir—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000173	0.0049	CbGpPWpGaD
Amprenavir—Anorexia—Cisplatin—bone cancer	0.000171	0.00786	CcSEcCtD
Amprenavir—ABCC1—Arachidonic acid metabolism—PTGS2—bone cancer	0.00017	0.00481	CbGpPWpGaD
Amprenavir—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000169	0.00479	CbGpPWpGaD
Amprenavir—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000169	0.00775	CcSEcCtD
Amprenavir—Abdominal discomfort—Methotrexate—bone cancer	0.000166	0.00762	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000165	0.0076	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000164	0.00751	CcSEcCtD
Amprenavir—Neutropenia—Methotrexate—bone cancer	0.000162	0.00744	CcSEcCtD
Amprenavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000161	0.00457	CbGpPWpGaD
Amprenavir—Paraesthesia—Cisplatin—bone cancer	0.000161	0.0074	CcSEcCtD
Amprenavir—Liver function test abnormal—Doxorubicin—bone cancer	0.00016	0.00736	CcSEcCtD
Amprenavir—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000159	0.00451	CbGpPWpGaD
Amprenavir—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000156	0.00718	CcSEcCtD
Amprenavir—Decreased appetite—Cisplatin—bone cancer	0.000156	0.00716	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Cisplatin—bone cancer	0.000155	0.00712	CcSEcCtD
Amprenavir—Depression—Methotrexate—bone cancer	0.000154	0.00707	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000153	0.00703	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000153	0.00703	CcSEcCtD
Amprenavir—Neutropenia—Epirubicin—bone cancer	0.000152	0.00696	CcSEcCtD
Amprenavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000148	0.0042	CbGpPWpGaD
Amprenavir—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000147	0.00417	CbGpPWpGaD
Amprenavir—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000147	0.00415	CbGpPWpGaD
Amprenavir—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000146	0.00415	CbGpPWpGaD
Amprenavir—Hyperglycaemia—Epirubicin—bone cancer	0.000146	0.00671	CcSEcCtD
Amprenavir—Hepatobiliary disease—Methotrexate—bone cancer	0.000146	0.00671	CcSEcCtD
Amprenavir—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000145	0.00411	CbGpPWpGaD
Amprenavir—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000143	0.00658	CcSEcCtD
Amprenavir—Neutropenia—Doxorubicin—bone cancer	0.00014	0.00644	CcSEcCtD
Amprenavir—Hepatobiliary disease—Epirubicin—bone cancer	0.000137	0.00628	CcSEcCtD
Amprenavir—Hyperglycaemia—Doxorubicin—bone cancer	0.000135	0.00621	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000133	0.00609	CcSEcCtD
Amprenavir—Erythema multiforme—Methotrexate—bone cancer	0.000131	0.00602	CcSEcCtD
Amprenavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000131	0.00371	CbGpPWpGaD
Amprenavir—Asthenia—Cisplatin—bone cancer	0.000129	0.00591	CcSEcCtD
Amprenavir—Cardiac disorder—Methotrexate—bone cancer	0.000129	0.00591	CcSEcCtD
Amprenavir—Connective tissue disorder—Epirubicin—bone cancer	0.000128	0.00585	CcSEcCtD
Amprenavir—Hepatobiliary disease—Doxorubicin—bone cancer	0.000126	0.00581	CcSEcCtD
Amprenavir—Diarrhoea—Cisplatin—bone cancer	0.000123	0.00564	CcSEcCtD
Amprenavir—Erythema multiforme—Epirubicin—bone cancer	0.000123	0.00563	CcSEcCtD
Amprenavir—Mental disorder—Methotrexate—bone cancer	0.000121	0.00558	CcSEcCtD
Amprenavir—Malnutrition—Methotrexate—bone cancer	0.000121	0.00554	CcSEcCtD
Amprenavir—Cardiac disorder—Epirubicin—bone cancer	0.00012	0.00553	CcSEcCtD
Amprenavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00012	0.00341	CbGpPWpGaD
Amprenavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000119	0.00338	CbGpPWpGaD
Amprenavir—Connective tissue disorder—Doxorubicin—bone cancer	0.000118	0.00542	CcSEcCtD
Amprenavir—Vomiting—Cisplatin—bone cancer	0.000114	0.00524	CcSEcCtD
Amprenavir—Mental disorder—Epirubicin—bone cancer	0.000114	0.00522	CcSEcCtD
Amprenavir—Erythema multiforme—Doxorubicin—bone cancer	0.000114	0.00521	CcSEcCtD
Amprenavir—Rash—Cisplatin—bone cancer	0.000113	0.0052	CcSEcCtD
Amprenavir—Dermatitis—Cisplatin—bone cancer	0.000113	0.00519	CcSEcCtD
Amprenavir—Malnutrition—Epirubicin—bone cancer	0.000113	0.00519	CcSEcCtD
Amprenavir—Cardiac disorder—Doxorubicin—bone cancer	0.000111	0.00512	CcSEcCtD
Amprenavir—Flatulence—Epirubicin—bone cancer	0.000111	0.00511	CcSEcCtD
Amprenavir—ABCC1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000109	0.0031	CbGpPWpGaD
Amprenavir—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	0.000109	0.00309	CbGpPWpGaD
Amprenavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000108	0.00306	CbGpPWpGaD
Amprenavir—Nausea—Cisplatin—bone cancer	0.000107	0.0049	CcSEcCtD
Amprenavir—Mental disorder—Doxorubicin—bone cancer	0.000105	0.00483	CcSEcCtD
Amprenavir—Malnutrition—Doxorubicin—bone cancer	0.000105	0.0048	CcSEcCtD
Amprenavir—Flatulence—Doxorubicin—bone cancer	0.000103	0.00473	CcSEcCtD
Amprenavir—Myalgia—Methotrexate—bone cancer	0.000103	0.00472	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000102	0.00469	CcSEcCtD
Amprenavir—Discomfort—Methotrexate—bone cancer	0.000102	0.00466	CcSEcCtD
Amprenavir—Nervous system disorder—Methotrexate—bone cancer	9.66e-05	0.00444	CcSEcCtD
Amprenavir—Myalgia—Epirubicin—bone cancer	9.62e-05	0.00442	CcSEcCtD
Amprenavir—Skin disorder—Methotrexate—bone cancer	9.57e-05	0.00439	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	9.55e-05	0.00438	CcSEcCtD
Amprenavir—Discomfort—Epirubicin—bone cancer	9.5e-05	0.00436	CcSEcCtD
Amprenavir—ABCC1—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.44e-05	0.00267	CbGpPWpGaD
Amprenavir—Anorexia—Methotrexate—bone cancer	9.39e-05	0.00431	CcSEcCtD
Amprenavir—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	9.27e-05	0.00263	CbGpPWpGaD
Amprenavir—CYP2B6—Biological oxidations—CYP3A4—bone cancer	9.2e-05	0.00261	CbGpPWpGaD
Amprenavir—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	9.07e-05	0.00257	CbGpPWpGaD
Amprenavir—Nervous system disorder—Epirubicin—bone cancer	9.04e-05	0.00415	CcSEcCtD
Amprenavir—CYP3A5—Biological oxidations—CYP3A4—bone cancer	8.99e-05	0.00255	CbGpPWpGaD
Amprenavir—Musculoskeletal discomfort—Methotrexate—bone cancer	8.97e-05	0.00412	CcSEcCtD
Amprenavir—Skin disorder—Epirubicin—bone cancer	8.95e-05	0.00411	CcSEcCtD
Amprenavir—Myalgia—Doxorubicin—bone cancer	8.9e-05	0.00409	CcSEcCtD
Amprenavir—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	8.87e-05	0.00251	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	8.85e-05	0.00251	CbGpPWpGaD
Amprenavir—Paraesthesia—Methotrexate—bone cancer	8.85e-05	0.00406	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	8.84e-05	0.00406	CcSEcCtD
Amprenavir—Discomfort—Doxorubicin—bone cancer	8.79e-05	0.00404	CcSEcCtD
Amprenavir—Anorexia—Epirubicin—bone cancer	8.79e-05	0.00403	CcSEcCtD
Amprenavir—Decreased appetite—Methotrexate—bone cancer	8.56e-05	0.00393	CcSEcCtD
Amprenavir—ABCC1—Metabolism—NDUFA12—bone cancer	8.55e-05	0.00242	CbGpPWpGaD
Amprenavir—Gastrointestinal disorder—Methotrexate—bone cancer	8.5e-05	0.0039	CcSEcCtD
Amprenavir—Fatigue—Methotrexate—bone cancer	8.49e-05	0.0039	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Epirubicin—bone cancer	8.4e-05	0.00386	CcSEcCtD
Amprenavir—Nervous system disorder—Doxorubicin—bone cancer	8.36e-05	0.00384	CcSEcCtD
Amprenavir—Skin disorder—Doxorubicin—bone cancer	8.29e-05	0.0038	CcSEcCtD
Amprenavir—Paraesthesia—Epirubicin—bone cancer	8.28e-05	0.0038	CcSEcCtD
Amprenavir—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	8.27e-05	0.00234	CbGpPWpGaD
Amprenavir—Anorexia—Doxorubicin—bone cancer	8.13e-05	0.00373	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methotrexate—bone cancer	8.06e-05	0.0037	CcSEcCtD
Amprenavir—Decreased appetite—Epirubicin—bone cancer	8.01e-05	0.00368	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Epirubicin—bone cancer	7.96e-05	0.00365	CcSEcCtD
Amprenavir—Fatigue—Epirubicin—bone cancer	7.95e-05	0.00365	CcSEcCtD
Amprenavir—CYP2B6—Biological oxidations—GSTP1—bone cancer	7.87e-05	0.00223	CbGpPWpGaD
Amprenavir—Abdominal pain—Methotrexate—bone cancer	7.79e-05	0.00358	CcSEcCtD
Amprenavir—CYP2C8—Biological oxidations—CYP3A4—bone cancer	7.79e-05	0.00221	CbGpPWpGaD
Amprenavir—Musculoskeletal discomfort—Doxorubicin—bone cancer	7.77e-05	0.00357	CcSEcCtD
Amprenavir—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	7.76e-05	0.0022	CbGpPWpGaD
Amprenavir—CYP3A5—Biological oxidations—GSTP1—bone cancer	7.69e-05	0.00218	CbGpPWpGaD
Amprenavir—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	7.68e-05	0.00218	CbGpPWpGaD
Amprenavir—Paraesthesia—Doxorubicin—bone cancer	7.66e-05	0.00352	CcSEcCtD
Amprenavir—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	7.58e-05	0.00215	CbGpPWpGaD
Amprenavir—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	7.54e-05	0.00214	CbGpPWpGaD
Amprenavir—Gastrointestinal pain—Epirubicin—bone cancer	7.54e-05	0.00346	CcSEcCtD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	7.52e-05	0.00213	CbGpPWpGaD
Amprenavir—Decreased appetite—Doxorubicin—bone cancer	7.41e-05	0.0034	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Doxorubicin—bone cancer	7.36e-05	0.00338	CcSEcCtD
Amprenavir—Fatigue—Doxorubicin—bone cancer	7.35e-05	0.00338	CcSEcCtD
Amprenavir—Abdominal pain—Epirubicin—bone cancer	7.29e-05	0.00335	CcSEcCtD
Amprenavir—ABCC1—Metabolism—NT5C3A—bone cancer	7.08e-05	0.00201	CbGpPWpGaD
Amprenavir—Asthenia—Methotrexate—bone cancer	7.07e-05	0.00325	CcSEcCtD
Amprenavir—Gastrointestinal pain—Doxorubicin—bone cancer	6.97e-05	0.0032	CcSEcCtD
Amprenavir—Pruritus—Methotrexate—bone cancer	6.97e-05	0.0032	CcSEcCtD
Amprenavir—CYP2C19—Biological oxidations—CYP3A4—bone cancer	6.95e-05	0.00197	CbGpPWpGaD
Amprenavir—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	6.85e-05	0.00194	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	6.85e-05	0.00194	CbGpPWpGaD
Amprenavir—Abdominal pain—Doxorubicin—bone cancer	6.74e-05	0.0031	CcSEcCtD
Amprenavir—Diarrhoea—Methotrexate—bone cancer	6.74e-05	0.00309	CcSEcCtD
Amprenavir—CYP2C8—Biological oxidations—GSTP1—bone cancer	6.66e-05	0.00189	CbGpPWpGaD
Amprenavir—Asthenia—Epirubicin—bone cancer	6.61e-05	0.00304	CcSEcCtD
Amprenavir—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	6.57e-05	0.00186	CbGpPWpGaD
Amprenavir—Pruritus—Epirubicin—bone cancer	6.52e-05	0.00299	CcSEcCtD
Amprenavir—CYP2D6—Biological oxidations—CYP3A4—bone cancer	6.39e-05	0.00181	CbGpPWpGaD
Amprenavir—CYP2C9—Biological oxidations—CYP3A4—bone cancer	6.34e-05	0.0018	CbGpPWpGaD
Amprenavir—Diarrhoea—Epirubicin—bone cancer	6.31e-05	0.0029	CcSEcCtD
Amprenavir—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	6.3e-05	0.00179	CbGpPWpGaD
Amprenavir—Vomiting—Methotrexate—bone cancer	6.26e-05	0.00288	CcSEcCtD
Amprenavir—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	6.25e-05	0.00177	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	6.24e-05	0.00177	CbGpPWpGaD
Amprenavir—Rash—Methotrexate—bone cancer	6.21e-05	0.00285	CcSEcCtD
Amprenavir—Dermatitis—Methotrexate—bone cancer	6.21e-05	0.00285	CcSEcCtD
Amprenavir—Headache—Methotrexate—bone cancer	6.17e-05	0.00283	CcSEcCtD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	6.15e-05	0.00174	CbGpPWpGaD
Amprenavir—Asthenia—Doxorubicin—bone cancer	6.12e-05	0.00281	CcSEcCtD
Amprenavir—Pruritus—Doxorubicin—bone cancer	6.03e-05	0.00277	CcSEcCtD
Amprenavir—CYP2C19—Biological oxidations—GSTP1—bone cancer	5.94e-05	0.00168	CbGpPWpGaD
Amprenavir—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	5.86e-05	0.00166	CbGpPWpGaD
Amprenavir—Vomiting—Epirubicin—bone cancer	5.86e-05	0.00269	CcSEcCtD
Amprenavir—Nausea—Methotrexate—bone cancer	5.85e-05	0.00269	CcSEcCtD
Amprenavir—Diarrhoea—Doxorubicin—bone cancer	5.84e-05	0.00268	CcSEcCtD
Amprenavir—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	5.83e-05	0.00165	CbGpPWpGaD
Amprenavir—Rash—Epirubicin—bone cancer	5.81e-05	0.00267	CcSEcCtD
Amprenavir—Dermatitis—Epirubicin—bone cancer	5.81e-05	0.00267	CcSEcCtD
Amprenavir—Headache—Epirubicin—bone cancer	5.78e-05	0.00265	CcSEcCtD
Amprenavir—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	5.52e-05	0.00156	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—NDUFA12—bone cancer	5.51e-05	0.00156	CbGpPWpGaD
Amprenavir—Nausea—Epirubicin—bone cancer	5.48e-05	0.00251	CcSEcCtD
Amprenavir—CYP2D6—Biological oxidations—GSTP1—bone cancer	5.47e-05	0.00155	CbGpPWpGaD
Amprenavir—Vomiting—Doxorubicin—bone cancer	5.42e-05	0.00249	CcSEcCtD
Amprenavir—CYP2C9—Biological oxidations—GSTP1—bone cancer	5.42e-05	0.00154	CbGpPWpGaD
Amprenavir—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	5.39e-05	0.00153	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—NDUFA12—bone cancer	5.39e-05	0.00153	CbGpPWpGaD
Amprenavir—Rash—Doxorubicin—bone cancer	5.38e-05	0.00247	CcSEcCtD
Amprenavir—Dermatitis—Doxorubicin—bone cancer	5.37e-05	0.00247	CcSEcCtD
Amprenavir—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	5.34e-05	0.00151	CbGpPWpGaD
Amprenavir—Headache—Doxorubicin—bone cancer	5.34e-05	0.00245	CcSEcCtD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	5.21e-05	0.00148	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.2e-05	0.00147	CbGpPWpGaD
Amprenavir—Nausea—Doxorubicin—bone cancer	5.07e-05	0.00233	CcSEcCtD
Amprenavir—CYP2C8—Metabolism—NDUFA12—bone cancer	4.67e-05	0.00132	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—NT5C3A—bone cancer	4.57e-05	0.00129	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.49e-05	0.00127	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—NT5C3A—bone cancer	4.46e-05	0.00126	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NDUFA12—bone cancer	4.17e-05	0.00118	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NDUFA12—bone cancer	4.07e-05	0.00115	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.87e-05	0.0011	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NT5C3A—bone cancer	3.87e-05	0.0011	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NDUFA12—bone cancer	3.83e-05	0.00109	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NDUFA12—bone cancer	3.8e-05	0.00108	CbGpPWpGaD
Amprenavir—ABCC1—Disease—ENO2—bone cancer	3.7e-05	0.00105	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.57e-05	0.00101	CbGpPWpGaD
Amprenavir—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.53e-05	0.000999	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NT5C3A—bone cancer	3.45e-05	0.000978	CbGpPWpGaD
Amprenavir—ABCC1—Disease—DHFR—bone cancer	3.44e-05	0.000973	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NT5C3A—bone cancer	3.37e-05	0.000954	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NT5C3A—bone cancer	3.17e-05	0.000899	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NT5C3A—bone cancer	3.15e-05	0.000892	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ENO2—bone cancer	3.1e-05	0.000879	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—DHFR—bone cancer	2.88e-05	0.000815	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.87e-05	0.000812	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.76e-05	0.000783	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GNA11—bone cancer	2.69e-05	0.000762	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NDUFA12—bone cancer	2.5e-05	0.00071	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.49e-05	0.000706	CbGpPWpGaD
Amprenavir—ABCC1—Disease—TGFBR2—bone cancer	2.49e-05	0.000705	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CYP3A4—bone cancer	2.44e-05	0.000691	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.43e-05	0.000687	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GSTP1—bone cancer	2.09e-05	0.000591	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NT5C3A—bone cancer	2.08e-05	0.000588	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ENO2—bone cancer	2e-05	0.000567	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.96e-05	0.000555	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ENO2—bone cancer	1.96e-05	0.000554	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—DHFR—bone cancer	1.86e-05	0.000526	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—DHFR—bone cancer	1.81e-05	0.000514	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GNA11—bone cancer	1.73e-05	0.000491	CbGpPWpGaD
Amprenavir—ABCC1—Disease—KIT—bone cancer	1.7e-05	0.000481	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GNA11—bone cancer	1.7e-05	0.00048	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ENO2—bone cancer	1.69e-05	0.00048	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.64e-05	0.000466	CbGpPWpGaD
Amprenavir—ABCC1—Disease—BRAF—bone cancer	1.6e-05	0.000452	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP3A4—bone cancer	1.57e-05	0.000446	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—DHFR—bone cancer	1.57e-05	0.000445	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP3A4—bone cancer	1.54e-05	0.000435	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ENO2—bone cancer	1.51e-05	0.000428	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ENO2—bone cancer	1.48e-05	0.000418	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GNA11—bone cancer	1.47e-05	0.000416	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—DHFR—bone cancer	1.4e-05	0.000397	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ENO2—bone cancer	1.39e-05	0.000394	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ENO2—bone cancer	1.38e-05	0.000391	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—DHFR—bone cancer	1.37e-05	0.000388	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTP1—bone cancer	1.35e-05	0.000381	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MDM2—bone cancer	1.34e-05	0.000379	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP3A4—bone cancer	1.33e-05	0.000377	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.32e-05	0.000375	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTP1—bone cancer	1.31e-05	0.000372	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GNA11—bone cancer	1.31e-05	0.000371	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—DHFR—bone cancer	1.29e-05	0.000365	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTGS2—bone cancer	1.29e-05	0.000365	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GNA11—bone cancer	1.28e-05	0.000362	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—DHFR—bone cancer	1.28e-05	0.000362	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GNA11—bone cancer	1.21e-05	0.000342	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GNA11—bone cancer	1.2e-05	0.000339	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP3A4—bone cancer	1.19e-05	0.000337	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.18e-05	0.000335	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP3A4—bone cancer	1.16e-05	0.000329	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTP1—bone cancer	1.14e-05	0.000323	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP3A4—bone cancer	1.09e-05	0.00031	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP3A4—bone cancer	1.08e-05	0.000307	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTGS2—bone cancer	1.08e-05	0.000306	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.08e-05	0.000305	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTP1—bone cancer	1.02e-05	0.000288	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTP1—bone cancer	9.92e-06	0.000281	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTP1—bone cancer	9.35e-06	0.000265	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTP1—bone cancer	9.27e-06	0.000263	CbGpPWpGaD
Amprenavir—ABCC1—Disease—EGFR—bone cancer	9.14e-06	0.000259	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ENO2—bone cancer	9.09e-06	0.000258	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—DHFR—bone cancer	8.43e-06	0.000239	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GNA11—bone cancer	7.88e-06	0.000223	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTGS2—bone cancer	6.97e-06	0.000197	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTGS2—bone cancer	6.81e-06	0.000193	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTP1—bone cancer	6.11e-06	0.000173	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTGS2—bone cancer	5.9e-06	0.000167	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTGS2—bone cancer	5.27e-06	0.000149	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTGS2—bone cancer	5.14e-06	0.000146	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTGS2—bone cancer	4.84e-06	0.000137	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTGS2—bone cancer	4.8e-06	0.000136	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS2—bone cancer	3.17e-06	8.97e-05	CbGpPWpGaD
